Global Signal Transduction Inhibitors Market Size, Status and Forecast 2021-2027

シグナル伝達阻害剤の世界市場規模・現状・予測2021年-2027年

◆タイトル:Global Signal Transduction Inhibitors Market Size, Status and Forecast 2021-2027
◆商品コード:QY21APR5236
◆調査・発行会社:QYResearch
◆発行日:2021年4月
◆ページ数:97
◆レポート形式:(印刷可能)PDF / 英語
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル、主要地域
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥444,600見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥666,900見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥889,200見積依頼/購入/質問フォーム
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常2日~3日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearchの日本における正規販売代理店です。

【レポートの概要】

本調査資料では、シグナル伝達阻害剤の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(ダサチニブ、エルロチニブ、ゲフィチニブ、イマチニブ、ラパチニブ、ニロチニブ、パゾパニブ、ソラフェニブ、スニチニブ)、用途別市場規模(病院薬局、小売薬局)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・シグナル伝達阻害剤の市場動向
・企業の競争状況、市場シェア
・シグナル伝達阻害剤の種類別市場規模(ダサチニブ、エルロチニブ、ゲフィチニブ、イマチニブ、ラパチニブ、ニロチニブ、パゾパニブ、ソラフェニブ、スニチニブ)
・シグナル伝達阻害剤の用途別市場規模(病院薬局、小売薬局)
・シグナル伝達阻害剤の北米市場規模2016-2027(アメリカ、カナダ)
・シグナル伝達阻害剤の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・シグナル伝達阻害剤のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・シグナル伝達阻害剤の中南米市場規模2016-2027(メキシコ、ブラジル)
・シグナル伝達阻害剤の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Bristol-Myers Squibb、Roche、AstraZeneca、GSK、Novartis、Amgen、Pfizer)
・結論

Signal transduction inhibitors are drugs that may prevent the ability of cancer cells to multiply quickly and invade other tissues.
Growing need for effective cancer diagnostics and innovative therapies for cancer treatment are expected to be the major factors driving the signal transduction inhibitors market.

Market Analysis and Insights: Global Signal Transduction Inhibitors Market
The global Signal Transduction Inhibitors market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Signal Transduction Inhibitors market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Signal Transduction Inhibitors market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Signal Transduction Inhibitors market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Signal Transduction Inhibitors market.

Global Signal Transduction Inhibitors Scope and Market Size
Signal Transduction Inhibitors market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Signal Transduction Inhibitors market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Dasatinib
Erlotinib
Gefitinib
Imatinib
Lapatinib
Nilotinib
Pazopanib
Sorafenib
Sunitinib

Segment by Application
Hospital Pharmacies
Retail Pharmacies

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Bristol-Myers Squibb
Roche
AstraZeneca
GSK
Novartis
Amgen
Pfizer

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Signal Transduction Inhibitors Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Dasatinib
1.2.3 Erlotinib
1.2.4 Gefitinib
1.2.5 Imatinib
1.2.6 Lapatinib
1.2.7 Nilotinib
1.2.8 Pazopanib
1.2.9 Sorafenib
1.2.10 Sunitinib
1.3 Market by Application
1.3.1 Global Signal Transduction Inhibitors Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Signal Transduction Inhibitors Market Perspective (2016-2027)
2.2 Signal Transduction Inhibitors Growth Trends by Regions
2.2.1 Signal Transduction Inhibitors Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Signal Transduction Inhibitors Historic Market Share by Regions (2016-2021)
2.2.3 Signal Transduction Inhibitors Forecasted Market Size by Regions (2022-2027)
2.3 Signal Transduction Inhibitors Industry Dynamic
2.3.1 Signal Transduction Inhibitors Market Trends
2.3.2 Signal Transduction Inhibitors Market Drivers
2.3.3 Signal Transduction Inhibitors Market Challenges
2.3.4 Signal Transduction Inhibitors Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Signal Transduction Inhibitors Players by Revenue
3.1.1 Global Top Signal Transduction Inhibitors Players by Revenue (2016-2021)
3.1.2 Global Signal Transduction Inhibitors Revenue Market Share by Players (2016-2021)
3.2 Global Signal Transduction Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Signal Transduction Inhibitors Revenue
3.4 Global Signal Transduction Inhibitors Market Concentration Ratio
3.4.1 Global Signal Transduction Inhibitors Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Signal Transduction Inhibitors Revenue in 2020
3.5 Signal Transduction Inhibitors Key Players Head office and Area Served
3.6 Key Players Signal Transduction Inhibitors Product Solution and Service
3.7 Date of Enter into Signal Transduction Inhibitors Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Signal Transduction Inhibitors Breakdown Data by Type
4.1 Global Signal Transduction Inhibitors Historic Market Size by Type (2016-2021)
4.2 Global Signal Transduction Inhibitors Forecasted Market Size by Type (2022-2027)

5 Signal Transduction Inhibitors Breakdown Data by Application
5.1 Global Signal Transduction Inhibitors Historic Market Size by Application (2016-2021)
5.2 Global Signal Transduction Inhibitors Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Signal Transduction Inhibitors Market Size (2016-2027)
6.2 North America Signal Transduction Inhibitors Market Size by Type
6.2.1 North America Signal Transduction Inhibitors Market Size by Type (2016-2021)
6.2.2 North America Signal Transduction Inhibitors Market Size by Type (2022-2027)
6.2.3 North America Signal Transduction Inhibitors Market Size by Type (2016-2027)
6.3 North America Signal Transduction Inhibitors Market Size by Application
6.3.1 North America Signal Transduction Inhibitors Market Size by Application (2016-2021)
6.3.2 North America Signal Transduction Inhibitors Market Size by Application (2022-2027)
6.3.3 North America Signal Transduction Inhibitors Market Size by Application (2016-2027)
6.4 North America Signal Transduction Inhibitors Market Size by Country
6.4.1 North America Signal Transduction Inhibitors Market Size by Country (2016-2021)
6.4.2 North America Signal Transduction Inhibitors Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Signal Transduction Inhibitors Market Size (2016-2027)
7.2 Europe Signal Transduction Inhibitors Market Size by Type
7.2.1 Europe Signal Transduction Inhibitors Market Size by Type (2016-2021)
7.2.2 Europe Signal Transduction Inhibitors Market Size by Type (2022-2027)
7.2.3 Europe Signal Transduction Inhibitors Market Size by Type (2016-2027)
7.3 Europe Signal Transduction Inhibitors Market Size by Application
7.3.1 Europe Signal Transduction Inhibitors Market Size by Application (2016-2021)
7.3.2 Europe Signal Transduction Inhibitors Market Size by Application (2022-2027)
7.3.3 Europe Signal Transduction Inhibitors Market Size by Application (2016-2027)
7.4 Europe Signal Transduction Inhibitors Market Size by Country
7.4.1 Europe Signal Transduction Inhibitors Market Size by Country (2016-2021)
7.4.2 Europe Signal Transduction Inhibitors Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Signal Transduction Inhibitors Market Size (2016-2027)
8.2 Asia-Pacific Signal Transduction Inhibitors Market Size by Type
8.2.1 Asia-Pacific Signal Transduction Inhibitors Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Signal Transduction Inhibitors Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Signal Transduction Inhibitors Market Size by Type (2016-2027)
8.3 Asia-Pacific Signal Transduction Inhibitors Market Size by Application
8.3.1 Asia-Pacific Signal Transduction Inhibitors Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Signal Transduction Inhibitors Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Signal Transduction Inhibitors Market Size by Application (2016-2027)
8.4 Asia-Pacific Signal Transduction Inhibitors Market Size by Region
8.4.1 Asia-Pacific Signal Transduction Inhibitors Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Signal Transduction Inhibitors Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Signal Transduction Inhibitors Market Size (2016-2027)
9.2 Latin America Signal Transduction Inhibitors Market Size by Type
9.2.1 Latin America Signal Transduction Inhibitors Market Size by Type (2016-2021)
9.2.2 Latin America Signal Transduction Inhibitors Market Size by Type (2022-2027)
9.2.3 Latin America Signal Transduction Inhibitors Market Size by Type (2016-2027)
9.3 Latin America Signal Transduction Inhibitors Market Size by Application
9.3.1 Latin America Signal Transduction Inhibitors Market Size by Application (2016-2021)
9.3.2 Latin America Signal Transduction Inhibitors Market Size by Application (2022-2027)
9.3.3 Latin America Signal Transduction Inhibitors Market Size by Application (2016-2027)
9.4 Latin America Signal Transduction Inhibitors Market Size by Country
9.4.1 Latin America Signal Transduction Inhibitors Market Size by Country (2016-2021)
9.4.2 Latin America Signal Transduction Inhibitors Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Signal Transduction Inhibitors Market Size (2016-2027)
10.2 Middle East & Africa Signal Transduction Inhibitors Market Size by Type
10.2.1 Middle East & Africa Signal Transduction Inhibitors Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Signal Transduction Inhibitors Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Signal Transduction Inhibitors Market Size by Type (2016-2027)
10.3 Middle East & Africa Signal Transduction Inhibitors Market Size by Application
10.3.1 Middle East & Africa Signal Transduction Inhibitors Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Signal Transduction Inhibitors Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Signal Transduction Inhibitors Market Size by Application (2016-2027)
10.4 Middle East & Africa Signal Transduction Inhibitors Market Size by Country
10.4.1 Middle East & Africa Signal Transduction Inhibitors Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Signal Transduction Inhibitors Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Bristol-Myers Squibb
11.1.1 Bristol-Myers Squibb Company Details
11.1.2 Bristol-Myers Squibb Business Overview
11.1.3 Bristol-Myers Squibb Signal Transduction Inhibitors Introduction
11.1.4 Bristol-Myers Squibb Revenue in Signal Transduction Inhibitors Business (2016-2021)
11.1.5 Bristol-Myers Squibb Recent Development
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche Signal Transduction Inhibitors Introduction
11.2.4 Roche Revenue in Signal Transduction Inhibitors Business (2016-2021)
11.2.5 Roche Recent Development
11.3 AstraZeneca
11.3.1 AstraZeneca Company Details
11.3.2 AstraZeneca Business Overview
11.3.3 AstraZeneca Signal Transduction Inhibitors Introduction
11.3.4 AstraZeneca Revenue in Signal Transduction Inhibitors Business (2016-2021)
11.3.5 AstraZeneca Recent Development
11.4 GSK
11.4.1 GSK Company Details
11.4.2 GSK Business Overview
11.4.3 GSK Signal Transduction Inhibitors Introduction
11.4.4 GSK Revenue in Signal Transduction Inhibitors Business (2016-2021)
11.4.5 GSK Recent Development
11.5 Novartis
11.5.1 Novartis Company Details
11.5.2 Novartis Business Overview
11.5.3 Novartis Signal Transduction Inhibitors Introduction
11.5.4 Novartis Revenue in Signal Transduction Inhibitors Business (2016-2021)
11.5.5 Novartis Recent Development
11.6 Amgen
11.6.1 Amgen Company Details
11.6.2 Amgen Business Overview
11.6.3 Amgen Signal Transduction Inhibitors Introduction
11.6.4 Amgen Revenue in Signal Transduction Inhibitors Business (2016-2021)
11.6.5 Amgen Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Signal Transduction Inhibitors Introduction
11.7.4 Pfizer Revenue in Signal Transduction Inhibitors Business (2016-2021)
11.7.5 Pfizer Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Signal Transduction Inhibitors Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Dasatinib
Table 3. Key Players of Erlotinib
Table 4. Key Players of Gefitinib
Table 5. Key Players of Imatinib
Table 6. Key Players of Lapatinib
Table 7. Key Players of Nilotinib
Table 8. Key Players of Pazopanib
Table 9. Key Players of Sorafenib
Table 10. Key Players of Sunitinib
Table 11. Global Signal Transduction Inhibitors Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 12. Global Signal Transduction Inhibitors Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 13. Global Signal Transduction Inhibitors Market Size by Regions (2016-2021) & (US$ Million)
Table 14. Global Signal Transduction Inhibitors Market Share by Regions (2016-2021)
Table 15. Global Signal Transduction Inhibitors Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 16. Global Signal Transduction Inhibitors Market Share by Regions (2022-2027)
Table 17. Signal Transduction Inhibitors Market Trends
Table 18. Signal Transduction Inhibitors Market Drivers
Table 19. Signal Transduction Inhibitors Market Challenges
Table 20. Signal Transduction Inhibitors Market Restraints
Table 21. Global Signal Transduction Inhibitors Revenue by Players (2016-2021) & (US$ Million)
Table 22. Global Signal Transduction Inhibitors Market Share by Players (2016-2021)
Table 23. Global Top Signal Transduction Inhibitors Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Signal Transduction Inhibitors as of 2020)
Table 24. Ranking of Global Top Signal Transduction Inhibitors Companies by Revenue (US$ Million) in 2020
Table 25. Global 5 Largest Players Market Share by Signal Transduction Inhibitors Revenue (CR5 and HHI) & (2016-2021)
Table 26. Key Players Headquarters and Area Served
Table 27. Key Players Signal Transduction Inhibitors Product Solution and Service
Table 28. Date of Enter into Signal Transduction Inhibitors Market
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Signal Transduction Inhibitors Market Size by Type (2016-2021) (US$ Million)
Table 31. Global Signal Transduction Inhibitors Revenue Market Share by Type (2016-2021)
Table 32. Global Signal Transduction Inhibitors Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 33. Global Signal Transduction Inhibitors Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 34. Global Signal Transduction Inhibitors Market Size Share by Application (2016-2021) & (US$ Million)
Table 35. Global Signal Transduction Inhibitors Revenue Market Share by Application (2016-2021)
Table 36. Global Signal Transduction Inhibitors Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 37. Global Signal Transduction Inhibitors Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 38. North America Signal Transduction Inhibitors Market Size by Type (2016-2021) (US$ Million)
Table 39. North America Signal Transduction Inhibitors Market Size by Type (2022-2027) & (US$ Million)
Table 40. North America Signal Transduction Inhibitors Market Size by Application (2016-2021) (US$ Million)
Table 41. North America Signal Transduction Inhibitors Market Size by Application (2022-2027) & (US$ Million)
Table 42. North America Signal Transduction Inhibitors Market Size by Country (2016-2021) & (US$ Million)
Table 43. North America Signal Transduction Inhibitors Market Size by Country (2022-2027) & (US$ Million)
Table 44. Europe Signal Transduction Inhibitors Market Size by Type (2016-2021) (US$ Million)
Table 45. Europe Signal Transduction Inhibitors Market Size by Type (2022-2027) & (US$ Million)
Table 46. Europe Signal Transduction Inhibitors Market Size by Application (2016-2021) (US$ Million)
Table 47. Europe Signal Transduction Inhibitors Market Size by Application (2022-2027) & (US$ Million)
Table 48. Europe Signal Transduction Inhibitors Market Size by Country (2016-2021) & (US$ Million)
Table 49. Europe Signal Transduction Inhibitors Market Size by Country (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Signal Transduction Inhibitors Market Size by Type (2016-2021) (US$ Million)
Table 51. Asia-Pacific Signal Transduction Inhibitors Market Size by Type (2022-2027) & (US$ Million)
Table 52. Asia-Pacific Signal Transduction Inhibitors Market Size by Application (2016-2021) (US$ Million)
Table 53. Asia-Pacific Signal Transduction Inhibitors Market Size by Application (2022-2027) & (US$ Million)
Table 54. Asia-Pacific Signal Transduction Inhibitors Market Size by Region (2016-2021) & (US$ Million)
Table 55. Asia-Pacific Signal Transduction Inhibitors Market Size by Region (2022-2027) & (US$ Million)
Table 56. Latin America Signal Transduction Inhibitors Market Size by Type (2016-2021) (US$ Million)
Table 57. Latin America Signal Transduction Inhibitors Market Size by Type (2022-2027) & (US$ Million)
Table 58. Latin America Signal Transduction Inhibitors Market Size by Application (2016-2021) (US$ Million)
Table 59. Latin America Signal Transduction Inhibitors Market Size by Application (2022-2027) & (US$ Million)
Table 60. Latin America Signal Transduction Inhibitors Market Size by Country (2016-2021) & (US$ Million)
Table 61. Latin America Signal Transduction Inhibitors Market Size by Country (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Signal Transduction Inhibitors Market Size by Type (2016-2021) (US$ Million)
Table 63. Middle East & Africa Signal Transduction Inhibitors Market Size by Type (2022-2027) & (US$ Million)
Table 64. Middle East & Africa Signal Transduction Inhibitors Market Size by Application (2016-2021) (US$ Million)
Table 65. Middle East & Africa Signal Transduction Inhibitors Market Size by Application (2022-2027) & (US$ Million)
Table 66. Middle East & Africa Signal Transduction Inhibitors Market Size by Country (2016-2021) & (US$ Million)
Table 67. Middle East & Africa Signal Transduction Inhibitors Market Size by Country (2022-2027) & (US$ Million)
Table 68. Bristol-Myers Squibb Company Details
Table 69. Bristol-Myers Squibb Business Overview
Table 70. Bristol-Myers Squibb Signal Transduction Inhibitors Product
Table 71. Bristol-Myers Squibb Revenue in Signal Transduction Inhibitors Business (2016-2021) & (US$ Million)
Table 72. Bristol-Myers Squibb Recent Development
Table 73. Roche Company Details
Table 74. Roche Business Overview
Table 75. Roche Signal Transduction Inhibitors Product
Table 76. Roche Revenue in Signal Transduction Inhibitors Business (2016-2021) & (US$ Million)
Table 77. Roche Recent Development
Table 78. AstraZeneca Company Details
Table 79. AstraZeneca Business Overview
Table 80. AstraZeneca Signal Transduction Inhibitors Product
Table 81. AstraZeneca Revenue in Signal Transduction Inhibitors Business (2016-2021) & (US$ Million)
Table 82. AstraZeneca Recent Development
Table 83. GSK Company Details
Table 84. GSK Business Overview
Table 85. GSK Signal Transduction Inhibitors Product
Table 86. GSK Revenue in Signal Transduction Inhibitors Business (2016-2021) & (US$ Million)
Table 87. GSK Recent Development
Table 88. Novartis Company Details
Table 89. Novartis Business Overview
Table 90. Novartis Signal Transduction Inhibitors Product
Table 91. Novartis Revenue in Signal Transduction Inhibitors Business (2016-2021) & (US$ Million)
Table 92. Novartis Recent Development
Table 93. Amgen Company Details
Table 94. Amgen Business Overview
Table 95. Amgen Signal Transduction Inhibitors Product
Table 96. Amgen Revenue in Signal Transduction Inhibitors Business (2016-2021) & (US$ Million)
Table 97. Amgen Recent Development
Table 98. Pfizer Company Details
Table 99. Pfizer Business Overview
Table 100. Pfizer Signal Transduction Inhibitors Product
Table 101. Pfizer Revenue in Signal Transduction Inhibitors Business (2016-2021) & (US$ Million)
Table 102. Pfizer Recent Development
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Signal Transduction Inhibitors Market Share by Type: 2020 VS 2027
Figure 2. Dasatinib Features
Figure 3. Erlotinib Features
Figure 4. Gefitinib Features
Figure 5. Imatinib Features
Figure 6. Lapatinib Features
Figure 7. Nilotinib Features
Figure 8. Pazopanib Features
Figure 9. Sorafenib Features
Figure 10. Sunitinib Features
Figure 11. Global Signal Transduction Inhibitors Market Share by Application: 2020 VS 2027
Figure 12. Hospital Pharmacies Case Studies
Figure 13. Retail Pharmacies Case Studies
Figure 14. Signal Transduction Inhibitors Report Years Considered
Figure 15. Global Signal Transduction Inhibitors Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 16. Global Signal Transduction Inhibitors Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 17. Global Signal Transduction Inhibitors Market Share by Regions: 2020 VS 2027
Figure 18. Global Signal Transduction Inhibitors Market Share by Regions (2022-2027)
Figure 19. Global Signal Transduction Inhibitors Market Share by Players in 2020
Figure 20. Global Top Signal Transduction Inhibitors Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Signal Transduction Inhibitors as of 2020
Figure 21. The Top 10 and 5 Players Market Share by Signal Transduction Inhibitors Revenue in 2020
Figure 22. Global Signal Transduction Inhibitors Revenue Market Share by Type (2016-2021)
Figure 23. Global Signal Transduction Inhibitors Revenue Market Share by Type (2022-2027)
Figure 24. North America Signal Transduction Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. North America Signal Transduction Inhibitors Market Share by Type (2016-2027)
Figure 26. North America Signal Transduction Inhibitors Market Share by Application (2016-2027)
Figure 27. North America Signal Transduction Inhibitors Market Share by Country (2016-2027)
Figure 28. United States Signal Transduction Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Canada Signal Transduction Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Signal Transduction Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe Signal Transduction Inhibitors Market Share by Type (2016-2027)
Figure 32. Europe Signal Transduction Inhibitors Market Share by Application (2016-2027)
Figure 33. Europe Signal Transduction Inhibitors Market Share by Country (2016-2027)
Figure 34. Germany Signal Transduction Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. France Signal Transduction Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. U.K. Signal Transduction Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Italy Signal Transduction Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Russia Signal Transduction Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Nordic Signal Transduction Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Signal Transduction Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific Signal Transduction Inhibitors Market Share by Type (2016-2027)
Figure 42. Asia-Pacific Signal Transduction Inhibitors Market Share by Application (2016-2027)
Figure 43. Asia-Pacific Signal Transduction Inhibitors Market Share by Region (2016-2027)
Figure 44. China Signal Transduction Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Japan Signal Transduction Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. South Korea Signal Transduction Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Southeast Asia Signal Transduction Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. India Signal Transduction Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Australia Signal Transduction Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Signal Transduction Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America Signal Transduction Inhibitors Market Share by Type (2016-2027)
Figure 52. Latin America Signal Transduction Inhibitors Market Share by Application (2016-2027)
Figure 53. Latin America Signal Transduction Inhibitors Market Share by Country (2016-2027)
Figure 54. Mexico Signal Transduction Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Brazil Signal Transduction Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Signal Transduction Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa Signal Transduction Inhibitors Market Share by Type (2016-2027)
Figure 58. Middle East & Africa Signal Transduction Inhibitors Market Share by Application (2016-2027)
Figure 59. Middle East & Africa Signal Transduction Inhibitors Market Share by Country (2016-2027)
Figure 60. Turkey Signal Transduction Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Saudi Arabia Signal Transduction Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. UAE Signal Transduction Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. Bristol-Myers Squibb Revenue Growth Rate in Signal Transduction Inhibitors Business (2016-2021)
Figure 64. Roche Revenue Growth Rate in Signal Transduction Inhibitors Business (2016-2021)
Figure 65. AstraZeneca Revenue Growth Rate in Signal Transduction Inhibitors Business (2016-2021)
Figure 66. GSK Revenue Growth Rate in Signal Transduction Inhibitors Business (2016-2021)
Figure 67. Novartis Revenue Growth Rate in Signal Transduction Inhibitors Business (2016-2021)
Figure 68. Amgen Revenue Growth Rate in Signal Transduction Inhibitors Business (2016-2021)
Figure 69. Pfizer Revenue Growth Rate in Signal Transduction Inhibitors Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed


【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[シグナル伝達阻害剤の世界市場規模・現状・予測2021年-2027年] (Global Signal Transduction Inhibitors Market Size, Status and Forecast 2021-2027 / QY21APR5236)についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆